Literature DB >> 31552468

[Treatment monitoring and innovations in amblyopia treatment].

Kai Januschowski1,2,3, Caroline Emmerich4, Annegret Abaza5, Henrike Julich-Haertel4, Annekatrin Rickmann4.   

Abstract

Technical innovations, such as computer games and shutter glasses open up elegant treatment options for amblyopia. The lack of monitoring of compliance means that there is no scientific basis on which a comparative study between a new therapeutic approach and occlusion therapy as the standard of care could be designed. An easy to use microsensor for measurement of compliance could have a broad spectrum of applications in scientific studies as well as in routine clinical practice. This article gives a brief overview about emerging and innovative approaches.

Entities:  

Keywords:  Compliance; Monitoring; Occlusion therapy; Usage protocol; Visual development

Year:  2019        PMID: 31552468     DOI: 10.1007/s00347-019-00970-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  44 in total

1.  A pilot randomized clinical trial of intermittent occlusion therapy liquid crystal glasses versus traditional patching for treatment of moderate unilateral amblyopia.

Authors:  Jingyun Wang; Daniel E Neely; Jay Galli; Joshua Schliesser; April Graves; Tina G Damarjian; Jessica Kovarik; James Bowsher; Heather A Smith; Dana Donaldson; Kathryn M Haider; Gavin J Roberts; Derek T Sprunger; David A Plager
Journal:  J AAPOS       Date:  2016-07-12       Impact factor: 1.220

2.  Compliance with occlusion therapy for childhood amblyopia.

Authors:  Michael P Wallace; Catherine E Stewart; Merrick J Moseley; David A Stephens; Alistair R Fielder
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-17       Impact factor: 4.799

3.  [Supportive amblyopia treatment by means of computer games with background stimulation; a placebo controlled pilot study of 10 days].

Authors:  U Kämpf; F Muchamedjarow; T Seiler
Journal:  Klin Monbl Augenheilkd       Date:  2001-04       Impact factor: 0.700

4.  Occlusion treatment for amblyopia: assessing the performance of the electronic occlusion dose monitor.

Authors:  Maria Fronius; Yaroslava Chopovska; Julia Nolden; Sjoukje E Loudon; Marc Lüchtenberg; Alina Zubcov; Larisa Pepler
Journal:  Strabismus       Date:  2006-06

5.  Predictors and a remedy for noncompliance with amblyopia therapy in children measured with the occlusion dose monitor.

Authors:  Sjoukje E Loudon; Maria Fronius; Caspar W N Looman; Musarat Awan; Brigitte Simonsz; Paul J van der Maas; Huibert J Simonsz
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-10       Impact factor: 4.799

6.  A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children.

Authors:  Jonathan M Holmes; Raymond T Kraker; Roy W Beck; Eileen E Birch; Susan A Cotter; Donald F Everett; Richard W Hertle; Graham E Quinn; Michael X Repka; Mitchell M Scheiman; David K Wallace
Journal:  Ophthalmology       Date:  2003-11       Impact factor: 12.079

7.  Measuring wearing times of glasses and ocular patches using a thermosensor device from orthodontics.

Authors:  Kai Januschowski; Till E Bechtold; Timm C Schott; Maren S Huelber-Januschowski; Gunnar Blumenstock; Karl-Ulrich Bartz-Schmidt; Dorothea Besch; Charlotte Schramm
Journal:  Acta Ophthalmol       Date:  2013-06-13       Impact factor: 3.761

8.  Electronic monitoring of occlusion treatment for amblyopia in patients aged 7 to 16 years.

Authors:  Maria Fronius; Iris Bachert; Marc Lüchtenberg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

9.  Treating amblyopia with liquid crystal glasses: a pilot study.

Authors:  Abraham Spierer; Judith Raz; Omry Benezra; Rafi Herzog; Evelyne Cohen; Ilana Karshai; David Benezra
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

10.  Effect of a Binocular iPad Game vs Part-time Patching in Children Aged 5 to 12 Years With Amblyopia: A Randomized Clinical Trial.

Authors:  Jonathan M Holmes; Vivian M Manh; Elizabeth L Lazar; Roy W Beck; Eileen E Birch; Raymond T Kraker; Eric R Crouch; S Ayse Erzurum; Nausheen Khuddus; Allison I Summers; David K Wallace
Journal:  JAMA Ophthalmol       Date:  2016-12-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.